Austin powers back, steroids for microbes, and heartbreak in Uganda

On this week’s episode, in association with Fasken, the team looks at the return of RockRose Energy founder Andrew Austin to the North Sea fold, after he sold up his former firm for nearly £250m earlier this year. Mark has been looking at an innovative new tech which uses microbes to significantly squeeze out extra barrels from North Sea fields, after a pilot at the CNOOC Scott platform. And rounding off, the EVOL team discuss how Covid-19 has forced Tullow to sell off its Uganda Lake Albert assets after more than 15 years, with a similar bittersweet story for Far Ltd in Senegal. 

Finally, with the UN Climate Change Conference (COP26) in Glasgow postponed until November 2021, we are bringing together some of the leading voices in the energy transition debate in our brand new virtual summit on November 19, 2020. Find out more, and register for the event, free, at etidex.co.uk.

Energy Voice helps organisations understand the geopolitical, economic and financial factors that underpin market events, and give you a view on what’s coming over the horizon. As a listener to this podcast, you can get a free trial of energyvoice.com, giving you two weeks of unrestricted access to the latest crucial news and insight. The trial is entirely without obligation – we don’t want your credit card, and there’s no auto-enrolment at the end. 

📧 Email trials@energyvoice.com to get the best market analysis in the world, free. 

🗣 To find out how to speak to over one million qualified users in global energy, through our peerless digital news and insight platform, visit https://www.energyvoice.com/content-services 

Bookmark and subscribe to energyvoice.com, sign up to our newsletter, and follow us on LinkedIn and Twitter. 

Ⓛ https://www.linkedin.com/showcase/energy-voice 

ⓣ https://twitter.com/EnergyVoiceNews 

• To accept the trial offer, email trials@energyvoice.com providing your name. 
• One of our sales team will set up as a user of the Energy Voice website, apply your trial allowance and email you to provide access instructions. 
• You will have two weeks of unlimited access from the point at which the trial allowance is instigated. At the end of the trial period you will retain your user account but will only be able to view a restricted number of articles as a free registered user (currently four per month). 
• You will not be automatically enrolled on a paid subscription at the end of the trial period. A member of the sales team will contact you to find out if you are interested in subscribing, provide options for subscription and payment if so, and process the transaction with your authorisation. Alternatively you can purchase a subscription directly from the website. 
• We retain the right to terminate trials and free registered user accounts without notice or explanation.